90Yttrium-epratuzumab

epratuzumab (Yttrium-90 labeled)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 90Yttrium-epratuzumab, covering 2017-01-19 to 2017-01-19. Get the full timeline:

Most recent: Clinical Trial Update: Study Evaluating the Efficacy of 90Yttrium-epratuzumab in Adults With CD22+ Relapsed/Refractory B-ALL [Phase 2]